Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Funder

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Biochimica Et Biophysica Acta|August 18, 2010
Aldosterone: a cardiovascular risk factor?John W Funder, Martin Reincke
The Lancet. Diabetes & Endocrinology|October 30, 2016
Adrenal vein sampling versus CT scanning in primary aldosteronismJohn W Funder, Gian Paolo Rossi
Hypertension (Dallas, Tex. : 1979)|January 24, 2022
Primary Aldosteronism: Where Are We Now? Where to From Here?John W Funder, Robert M Carey
Journal of Hypertension|August 13, 2002
Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular systemMorag J Young, John W Funder
Steroids|May 3, 2005
Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular systemAnastasia S Mihailidou, John W Funder
Hypertension (Dallas, Tex. : 1979)|December 13, 2017
Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Pro Side of the ArgumentGian Paolo Rossi, John W Funder
Molecular and Cellular Endocrinology|November 26, 2008
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biologyJohn W Funder, Anastasia S Mihailidou
Hypertension (Dallas, Tex. : 1979)|February 1, 2017
Adrenal Venous Sampling Versus Computed Tomographic Scan to Determine Treatment in Primary Aldosteronism (The SPARTACUS Trial): A CritiqueGian Paolo Rossi, John W Funder
The Journal of Endocrinology|June 22, 2017
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The scientific impact of cloning the mineralocorticoid receptor: 30 years onJohn W Funder, Maria-Christina Zennaro
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 17, 2006
Combination therapy with aldosterone blockade and renin-angiotensin inhibitors confers organ protectionAtsuhisa Sato, Takao Saruta, John W Funder
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Biochimica Et Biophysica Acta|August 18, 2010
Aldosterone: a cardiovascular risk factor?John W Funder, Martin Reincke
The Lancet. Diabetes & Endocrinology|October 30, 2016
Adrenal vein sampling versus CT scanning in primary aldosteronismJohn W Funder, Gian Paolo Rossi
Hypertension (Dallas, Tex. : 1979)|January 24, 2022
Primary Aldosteronism: Where Are We Now? Where to From Here?John W Funder, Robert M Carey
Journal of Hypertension|August 13, 2002
Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular systemMorag J Young, John W Funder
Steroids|May 3, 2005
Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular systemAnastasia S Mihailidou, John W Funder
Hypertension (Dallas, Tex. : 1979)|December 13, 2017
Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Pro Side of the ArgumentGian Paolo Rossi, John W Funder
Molecular and Cellular Endocrinology|November 26, 2008
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biologyJohn W Funder, Anastasia S Mihailidou
Hypertension (Dallas, Tex. : 1979)|February 1, 2017
Adrenal Venous Sampling Versus Computed Tomographic Scan to Determine Treatment in Primary Aldosteronism (The SPARTACUS Trial): A CritiqueGian Paolo Rossi, John W Funder
The Journal of Endocrinology|June 22, 2017
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The scientific impact of cloning the mineralocorticoid receptor: 30 years onJohn W Funder, Maria-Christina Zennaro
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 17, 2006
Combination therapy with aldosterone blockade and renin-angiotensin inhibitors confers organ protectionAtsuhisa Sato, Takao Saruta, John W Funder
Pageof 14